Top Image
Advanced Centre for Treatment Research & Education in Cancer
Facebook Twitter Gmail
Banner Image
Science Sparks @ ACTREC
Date Image 16 October 2023 Vol. No. 12; Issue No. 600

1. Ambatipudi S, Inchanalkar M, Mahimkar MB (2023). Role of DNA methylation-based mitotic ageing indices in oral cancer development and recurrence. Oral Diseases.

Site of the Week

The XDeathDB visualization platform provides a comprehensive cell death and their crosstalk resource for deciphering the signaling network organization of interactions among different cell death modes associated with many cancer types

desktop Image
Interesting Reads

Mossmann D, Müller C, Park S, Ryback B, Colombi M, Ritter N, Weißenberger D, Dazert E, Coto-Llerena M, Nuciforo S, Blukacz L, Ercan C, Jimenez V, Piscuoglio S, Bosch F, Terracciano LM, Sauer U, Heim MH, Hall MN (2023). Arginine reprograms metabolism in liver cancer via RBM39. Cell.

Video of the Week
Translational Dysequilibrium at the Bedside-Bench Interface
Upcoming Events
AACR On Campus at ACTREC, Tata Memorial Centre

31 Oct-01 Nov, 2023

At Tata Memorial Centre Advanced Centre for Treatment, Research and Education in Cancer, Kharghar, Navi Mumbai, India.

11th International Conference and Preconference Workshop of Laboratory Animal Scientists’ Association (LASA)

06-08 November, 2023

At J N Tata Auditorium, National Science Seminar Complex, Indian Institute of Science, Bengaluru.

Precision Oncology Europe 2023

14-15 November, 2023

At Berlin, Germany.

Do You Know?

In 2009, FDA approved Cervarix, a second vaccine that protects against infection by the two HPV types that cause approximately 70% of all cases of cervical cancer worldwide.

back Image
Cancer News
Drug-filled nanocapsule helps make immunotherapy more effective in mice

11 October 2023, ScienceDaily

Researchers have developed a new treatment method using a tiny nanocapsule to help boost the immune response, making it easier for the immune system to fight and kill solid tumors...

Oncolytic virus enables the immune system to attack tumors

12 October 2023, National Cancer Institute

In the new study, researchers created a modified oncolytic virus that can transport the genetic instructions for a potent cancer treatment directly into cancer cells...

India’s first cell therapy for cancer treatment receives regulatory approval

14 October 2023, Hindustan Times

The Central Drugs Standard Control Organization (CDSCO) has issued market authorisation to CAR-T (Chimeric Antigen Receptor-T) cell therapy, a breakthrough treatment for treating relapsed/refractory (r/r) B-cell lymphomas and leukaemia, paving the way for its commercial launch of indigenous NexCAR19 in the country. ImmunoACT, an IIT Bombay incubated company, developed the treatment. Both ImmunoACT and Tata Memorial Centre (TMC) collaborated to invent indigenous CAR-T Cell Therapy, a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a laboratory to enable them to locate and destroy cancer cells more effectively...

2019 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)